Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Advanced Breast Cancer|Hormone Receptor Positive Breast Carcinoma|HER2-negative Breast Cancer
Sponsor: University of Milano Bicocca